FdaApplication
ANDA 212559
Identifiers
- fda_app_no: ANDA212559
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2025-08-08 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IRON SUCROSE | IRON SUCROSE | EQ 200MG IRON/10ML (EQ 20MG IRON/ML) | INJECTABLE;INTRAVENOUS |
| IRON SUCROSE | IRON SUCROSE | EQ 100MG IRON/5ML (EQ 20MG IRON/ML) | INJECTABLE;INTRAVENOUS |
| IRON SUCROSE | IRON SUCROSE | EQ 50MG IRON/2.5ML (EQ 20MG IRON/ML) | INJECTABLE;INTRAVENOUS |
3 products